Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Replicel Life Sciences Inc (RP) NPV

Sell:0.35 CAD Buy:0.36 CAD Change: No change
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:0.35 CAD
Buy:0.36 CAD
Change: No change
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:0.35 CAD
Buy:0.36 CAD
Change: No change
Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Replicel Life Sciences Inc is a Canada-based regenerative medicine company. It develops autologous cell therapies that treat functional cellular deficits. Its product pipeline includes RCT-01-Tendon Repair, RCS-01-Skin Rejuvenation, RCH-01-Hair Regeneration and RCI-02-Dermal Injector. RCT-01 is an autologous cell-based treatment utilizing non-bulbar dermal sheath cells isolated from the hair follicle sheath to treat chronic tendinosis caused by acute and chronic tensile overuse. RCH-01 also utilizes dermal sheath cup cells isolated from the hair follicle to treat androgenetic alopecia. RCI-02 is a dermal injector designed to control intradermal (dermis), subcutaneous (fat) or intramuscular injections. It is designed to support the injection of RCH-01 and RCS-01 cell therapy products. The injector has applications for dermatological procedures requiring injections of specific volumes of material at specific depths, including cellular products, fillers and collagen injections.

Contact details

Address:
570 Granville St Suite 900
VANCOUVER
V6C 3P1
Canada
Telephone:
+1 (604) 2488693
Website:
https://replicel.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
RP
ISIN:
CA76027P4006
Market cap:
9.50 million CAD
Shares in issue:
27.54 million
Sector:
Life Sciences Tools & Services
Exchange:
Canadian Venture Exchange
Country:
Canada
Currency:
Canadian dollars
Indices:
n/a

Key personnel

  • David Hall
    Chairman of the Board
  • R. Lee Buckler
    President, Chief Executive Officer, Director
  • Simon Ma
    Chief Financial Officer
  • Brooke Hurford
    Director - Finance, Corporate Secretary
  • Kevin McElwee
    Chief Scientific Officer
  • Gemma Fetterley
    Vice President - Finance, Treasurer
  • Darrell Panich
    Vice President - Clinical Affairs
  • Rolf Hoffmann
    Chief Medical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.